Amgen sales and marketing update

AMGN announced that it expects a modest reduction in the growth rate of sales of Epogen erythropoietin for 1997 based on new Medicare reimbursement guidelines

Read the full 253 word article

How to gain access

Continue reading with a
two-week free trial.